Puma Biotechnology, Inc.
PBYI
$7.17
$0.091.27%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/8/2026
-
MarketBeat
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
5/11/2026
-
Simply Wall St
5/10/2026
-
The Cerbat Gem
5/10/2026
-
MarketBeat
5/9/2026
-
Simply Wall St
5/8/2026
-
MarketBeat
5/8/2026
-
Zacks Investment Research
5/8/2026
-
Zacks Investment Research
5/8/2026
-
SeekingAlpha
5/8/2026
-
Seeking Alpha: Transcripts
5/8/2026
-
SeekingAlpha
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/7/2026
-
The Fly
5/7/2026
-
Business Wire
5/7/2026
-
MarketBeat
5/6/2026
-
Business Wire
5/5/2026
-
The Cerbat Gem
5/4/2026
-
Zacks Investment Research
4/30/2026
-
MarketBeat
4/30/2026
-
Tickeron - Stocks
4/29/2026
-
MarketBeat
4/25/2026
-
Tickeron - Technical Analysis
4/24/2026
-
Tickeron - Technical Analysis
4/24/2026
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
424 248 6500
Address
10880 Wilshire Boulevard
Los Angeles, CA 90024
Los Angeles, CA 90024
Country
Year Founded
Business Description
Sector
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers...
more